錦興國際控股(02307.HK)上半年普通股權持有人應占溢利640萬港元 同比增加68%
格隆匯8月19日丨錦興國際控股(02307.HK)公吿,2025年上半年,集團的整體收益同比增加約1.8%至約18.43億港元,毛利同比增加約5.9%至約2.09億港元。集團錄得普通股權持有人應占溢利640萬港元,同比增加68.0%。於期間內的每股基本盈利約為0.7港仙。
儘管市場競爭激烈及存在地緣政治不明朗因素,集團的紡織及成衣業務仍保持穩定的表現。由於集團的紡織產品主要銷售予亞洲的成衣生產商,而成衣產品則出口至歐洲及加拿大,故美國關税對本集團的直接影響甚微。另一方面,集團的"中國+越南+柬埔寨"生產鐵三角有所強化,憑藉多地點生產解決方案確保取得全球品牌客户的訂單。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.